Sign In
Buy EKTAY
$4.93
-0.0950 (-1.89%)
At Close: Jun 22, 2026
Elekta AB (publ) (EKTAY) Analyst/Investor Day Transcript
07:02pm, Wednesday, 17'th Jun 2026
Elekta AB (publ) (EKTAY) Analyst/Investor Day Transcript
Elekta AB (publ) (EKTAY) Q4 2026 Earnings Call Transcript
08:14am, Thursday, 28'th May 2026
Elekta AB (publ) (EKTAY) Q4 2026 Earnings Call Transcript
Elekta AB: Tricky, But With A Latent Upside
10:58am, Tuesday, 19'th May 2026
Elekta AB (publ) is rated Buy with a 56 SEK ($6 ADR) price target, reflecting a 15% annualized return potential at 15x P/E. EKTAY's historical premium is no longer justified due to persistent earnings
Elekta AB (publ) (EKTAY) Q3 2026 Earnings Call Transcript
06:42am, Thursday, 05'th Mar 2026
Elekta AB (publ) (EKTAY) Q3 2026 Earnings Call Transcript
Analyzing Anteris Technologies Global (NASDAQ:AVR) and Elekta (OTCMKTS:EKTAY)
03:39am, Friday, 20'th Feb 2026
Anteris Technologies Global (NASDAQ: AVR - Get Free Report) and Elekta (OTCMKTS:EKTAY - Get Free Report) are both medical companies, but which is the better business? We will contrast the two business
Elekta AB (publ) (EKTAY) Shareholder/Analyst Call Transcript
05:10pm, Friday, 30'th Jan 2026
Elekta AB (publ) (EKTAY) Shareholder/Analyst Call Transcript
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
01:41pm, Monday, 19'th Jan 2026
EKTAY jumps after FDA clears Evo CT-Linac, opening U.S. access to AI-driven CT imaging that boosts precision and efficiency in radiation therapy.
Elekta AB (publ) (EKTAY) Q2 2026 Earnings Call Transcript
08:13am, Wednesday, 26'th Nov 2025
Elekta AB (publ) (OTCPK:EKTAY) Q2 2026 Earnings Call November 26, 2025 4:00 AM EST Company Participants Peter Nyquist - Head of Investor Relations Jakob Just-Bomholt - CEO & President Tobias Hagglov -
Elekta AB (publ) (EKTAF) Q1 2026 Earnings Call Transcript
08:43am, Thursday, 28'th Aug 2025
Elekta AB (publ) (OTCPK:EKTAF) Q1 2026 Earnings Conference Call August 28, 2025 4:00 AM ET Company Participants Jonas Bolander - Acting President & CEO Peter Nyquist - Head of Investor Relations Tobia
New Strong Sell Stocks for July 24th
06:06am, Thursday, 24'th Jul 2025
COMP, EKTAY and BLCO have been added to the Zacks Rank #5 (Strong Sell) List on July 24, 2025.
Elekta AB: Latent Growth And A Recurring Base
01:07pm, Wednesday, 04'th Jun 2025
Elekta operates in a secularly growing cancer radiotherapy market, with strong long-term demand drivers, especially in emerging markets. The company boasts solid free cash flow yield and a growing rec
Elekta AB (publ) (EKTAF) Q4 2025 Earnings Call Transcript
03:05pm, Wednesday, 28'th May 2025
Elekta AB (publ) (OTCPK:EKTAF) Q4 2025 Results Conference Call May 28, 2025 4:00 AM ET Company Participants Peter Nyquist - Head of Investor Relations Jonas Bolander - Acting President & Chief Executi
Should Value Investors Buy Elekta (EKTAY) Stock?
10:45am, Tuesday, 29'th Apr 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Elekta AB (publ) (EKTAF) Q3 2025 Earnings Call Transcript
10:17am, Friday, 21'st Feb 2025
Elekta AB (publ) (OTCPK:EKTAF) Q3 2025 Earnings Conference Call February 21, 2025 4:00 AM ET Company Participants Peter Nyquist - Head of Investor Relations Gustaf Salford - President and CEO Tobias H
Elekta AB (publ) (EKTAF) Q2 2025 Earnings Call Transcript
10:48am, Wednesday, 27'th Nov 2024
Elekta AB (publ) (OTCPK:EKTAF) Q2 2025 Earnings Conference Call November 27, 2024 4:00 AM ET Company Participants Peter Nyquist - Head of Investor Relations Gustaf Salford - President and Chief Execut
